Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.20 CAD
−288.62 K CAD
152.48 M CAD
29.75 M
About MEDEXUS PHARMACEUTICALS INC
Sector
Industry
CEO
Kenneth d’Entremont
Website
Headquarters
Bolton
Founded
2003
FIGI
BBG0029BPQX0
Medexus Pharmaceuticals, Inc. operates as a pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and treatment solutions focusing on therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology. The firm products include IXINITY, Rasuvo, Metoject, Rupall, and Gleolan. The company was founded in 2003 and is headquartered in Bolton, Canada.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of MDP is 2.70 CAD — it has decreased by −2.53% in the past 24 hours. Watch MEDEXUS PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange MEDEXUS PHARMACEUTICALS INC stocks are traded under the ticker MDP.
MDP stock has risen by 12.50% compared to the previous week, the month change is a 5.88% rise, over the last year MEDEXUS PHARMACEUTICALS INC has showed a 53.41% increase.
We've gathered analysts' opinions on MEDEXUS PHARMACEUTICALS INC future price: according to them, MDP price has a max estimate of 7.70 CAD and a min estimate of 3.34 CAD. Watch MDP chart and read a more detailed MEDEXUS PHARMACEUTICALS INC stock forecast: see what analysts think of MEDEXUS PHARMACEUTICALS INC and suggest that you do with its stocks.
MDP stock is 5.22% volatile and has beta coefficient of 1.33. Track MEDEXUS PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is MEDEXUS PHARMACEUTICALS INC there?
Today MEDEXUS PHARMACEUTICALS INC has the market capitalization of 87.10 M, it has increased by 20.28% over the last week.
Yes, you can track MEDEXUS PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
MEDEXUS PHARMACEUTICALS INC is going to release the next earnings report on Jul 1, 2025. Keep track of upcoming events with our Earnings Calendar.
MDP earnings for the last quarter are 0.043 CAD per share, whereas the estimation was 0.051 CAD resulting in a −15.93% surprise. The estimated earnings for the next quarter are −0.097 CAD per share. See more details about MEDEXUS PHARMACEUTICALS INC earnings.
MEDEXUS PHARMACEUTICALS INC revenue for the last quarter amounts to 43.16 M CAD, despite the estimated figure of 40.76 M CAD. In the next quarter, revenue is expected to reach 36.13 M CAD.
MDP net income for the last quarter is 1.03 M CAD, while the quarter before that showed 150.04 K CAD of net income which accounts for 583.20% change. Track more MEDEXUS PHARMACEUTICALS INC financial stats to get the full picture.
No, MDP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 27, 2025, the company has 82 employees. See our rating of the largest employees — is MEDEXUS PHARMACEUTICALS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDEXUS PHARMACEUTICALS INC EBITDA is 28.62 M CAD, and current EBITDA margin is 16.45%. See more stats in MEDEXUS PHARMACEUTICALS INC financial statements.
Like other stocks, MDP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDEXUS PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDEXUS PHARMACEUTICALS INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDEXUS PHARMACEUTICALS INC stock shows the neutral signal. See more of MEDEXUS PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.